A detailed history of Quintet Private Bank (Europe) S.A. transactions in Dexcom Inc stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 4,105 shares of DXCM stock, worth $328,564. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,105
Previous 968 324.07%
Holding current value
$328,564
Previous $125 Million 120.23%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$64.0 - $116.06 $200,768 - $364,080
3,137 Added 324.07%
4,105 $275 Million
Q2 2024

Jul 24, 2024

BUY
$110.31 - $140.45 $106,780 - $135,955
968 New
968 $125 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Quintet Private Bank (Europe) S.A. Portfolio

Follow Quintet Private Bank (Europe) S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quintet Private Bank (Europe) S.A., based on Form 13F filings with the SEC.

News

Stay updated on Quintet Private Bank (Europe) S.A. with notifications on news.